Speakers - Sachs Associates
Speakers - Sachs Associates
Speakers - Sachs Associates
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
CONTACTS<br />
Kevin FitzGerald<br />
Chief Operating Officer<br />
Ghaz Mahdizadeh<br />
EA<br />
ADDRESS<br />
London BioScience Innovation<br />
Centre<br />
2 Royal College Street<br />
London NW1 0NH<br />
TELEPHONE<br />
+44 020 7691 4908<br />
EMAIL<br />
Kevin.FitzGerald<br />
@its-innovation.com<br />
Ghaz.mahdizadeh<br />
@its-innovation.com<br />
YEAR FOUNDED<br />
2004<br />
Immune Targeting Systems<br />
www.its-innovation.com<br />
FINANCIAL SUMMARY<br />
The Company is supported by leading investors including Novartis Venture Fund, HealthCap, Truffle Capital, SME<br />
Wholesale Finance and Esperante Ventures and has raised £14.5m to-date. The Company is currently seeking<br />
investors to participate in a series-B financing.<br />
COMPANY PROFILE<br />
Immune Targeting Systems is an emerging leader in the development of vaccine products that work by<br />
promoting T-cell responses against viruses and cancers (“T-cell vaccines”). The company’s lead product<br />
Flunisyn, currently in clinical development, is a novel T-cell vaccine which elicits potent cellular immune<br />
responses against multiple strains of influenza. The Company’s technology also supports a product portfolio<br />
which includes Hepsyn-B, an attractive therapeutic hepatitis B vaccine and T-cell vaccines against cancers.<br />
MANAGEMENT<br />
Kevin FitzGerald, PhD MBA, Chief Operating Officer<br />
• Serial life sciences entrepreneur with over twenty years’ experience within the biotechnology industry;<br />
• Scientific, commercial and strategic expertise;<br />
• CEO of F-star, founder & CEO of Isogenica and among the founding group of scientists at Cambridge Antibody Technology;<br />
• Capital-raising expertise (more than €30m raised to date);<br />
• Substantial business development experience (deals closed with Amgen, AstraZeneca, Boehringer Ingelheim, Centocor, GE<br />
Healthcare, Johnson & Johnson, Merck Serono, Pfizer, UCB-Celltech and Wyeth etc.).<br />
t back :: next u<br />
WELCOME PHARMA LICENSING GROUPS<br />
SPEAKERS<br />
PRESENTING COMPANIES SUPPORTING ORGANISATIONS<br />
ORGANISERS